Tumor necrosis factor receptor superfamily 10B (TNFRSF10B): An insight from structure modeling to virtual screening for designing drug against head and neck cancer

Theoretical Biology and Medical Modelling

Volumn 10, Issue 1, 2013, Pages

  Tahir, Rana Adnan ^a   Sehgal, Sheikh Arslan ^b   Khattak, Naureen Aslam ^c   Khan Khattak, Jabar Zaman ^a   Mir, Asif ^a  

^a INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

^c PMAS ARID AGRICULTURE UNIVERSITY   (Pakistan)

Author keywords

Bioinformatics; Docking; Head and neck cancer; Inhibitors; Modeling; MODELLER; Phylogenetic; TNFRSF10B; Tumor necrosis factor; Virtual screening

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; TNFRSF10B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL; ARTICLE; BRAIN HEMORRHAGE; C57BL MOUSE; CONVALESCENCE; DISEASE MODEL; DRUG ANTAGONISM; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; MOUSE; NEUROLOGIC DISEASE; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; HEAD AND NECK NEOPLASMS; HUMAN; HEAD AND NECK TUMOR;

ANIMALS; ANTIBODIES, MONOCLONAL; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NERVOUS SYSTEM DISEASES; RANDOM ALLOCATION; RECOVERY OF FUNCTION; TUMOR NECROSIS FACTOR-ALPHA; ANTINEOPLASTIC AGENTS; DRUG DESIGN; HEAD AND NECK NEOPLASMS; HUMANS; MODELS, MOLECULAR; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84878358673     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-10-38     Document Type: Article

References (34)

1. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Devasena A, Pranay MC, Sadhana K, Rajani AB, Manoj BM, Carcinogenesis 2007 28 1455 1462
2. Institution-based cancer incidence in a local population in Pakistan: nine year data analysis. Hanif M, Zaidi P, Kamal S, Hameed A, Asia Pac J Cancer Prev 2009 10 227 230
3. Head and neck cancer. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK, N Eng J Med 1993 328 184 194
4. Genetic susceptibility-molecular epidemiology of head and neck cancer. Sturgis EM, Wei Q, Curr Opin Oncol 2002 14 310 317 (Pubitemid 34492864)
5. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Hashibe M, Boffetta P, Zaridze D, Cancer Epidemiol Biomarkers Prev 2006 15 696 703
6. Genetic instability in epithelial tissues at risk for cancer. Hittelman WN, Ann N Y Acad Sci 2001 952 1 12 (Pubitemid 34060005)
7. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Ha PK, Califano JA, Lancet Oncol 2006 7 77 82 (Pubitemid 43025396)
8. Molecular biology of squamous cell carcinoma of the head and neck. Perez-Ordonez B, Beauchemin M, Jordan RC, J Clin Pathol 2006 59 445 453
9. TNFRSF10B polymorphisms and haplotypes predicts survival in non-small cell lung cancer patients. Schabath MB, Giuliano AR, Thompson Z, Fenstermacher D, Jonathan K, Sellers TA, Haura E, Cancer Res 2012 72 4506 4520
10. Rare loss-of-function mutation of a death receptor gene in head and neck cancer. Pai SI, Wu GS, Ozoren N, Wu L, Jen J, Sidransky D, El-Deiry WS, Cancer Res 1998 58 3513 3518 (Pubitemid 28376541)
11. Protein structure modeling with MODELLER. Eswar N, Eramian D, Webb B, Shen MY, Sali A, Methods Mol Biol 2008 426 145 159
12. UCSF Chimera-a visualization system for exploratory research and analysis. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE, J Comput Chem 2004 25 1605 1612
13. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S, Mol Biol Evol 2011 28 2731 2739
14. Structure-based discovery and in-parallel optimization of novel competitive inhibitors of thymidylate synthase. Tondi D, Slomczynska U, Costi MP, Watterson DM, Ghelli S, Shoichet BK, Chem Biol 1999 6 319 331 (Pubitemid 29363182)
15. Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties. Ertl P, Rohde B, Selzer P, J Med Chem 2000 43 3714 3717
16. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ, Adv Drug Deliv Rev 1997 23 3 25 (Pubitemid 27046991)
17. Selection criteria for drug-like compounds. Muegge I, Med Res Rev 2003 23 302 321 (Pubitemid 36457537)
18. http://Mcule.com: a public web service for drug discovery. Kiss R, Sandor M, Szalai FA, J Chem Inform 2012 4 17
19. Drugs, leads, and drug-likeness: an analysis of some recently launched drugs. Proudfoot JR, Bioorg Med Chem Lett 2002 12 1647 1650 (Pubitemid 34569263)
20. OSIRIS, 2001 http://www.organic-chemistry.org/prog/peo/
21. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von-Mering C, Jensen LJ, Nucleic Acids Res 2013 41 808 815
22. STITCH 3: zooming in on protein-chemical interactions. Kuhn M, Szklarczyk D, Franceschini A, Mering CV, Jensen LJ, Bork P, Nucl Acids Res 2012 40 876 880
23. GRAMM-X public web server for protein-protein docking. Tovchigrechko A, Vakser IA, Nucleic Acids Res 2006 34 310 314
24. HexServer: an FFT-based protein docking server powered by graphics processors. Macindoe G, Mavridis L, Venkatraman V, Devignes MD, Ritchie DW, Nucleic Acids Res 2010 38 445 449
25. Head and neck cancer. Forastiere A, Koch W, Trotti A, Sidransky D, N Engl J Med 2001 345 1890 1900 (Pubitemid 33716564)
26. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Scully C, Field JK, Tanzawa H, Oral Oncol 2000 36 256 263 (Pubitemid 30227706)
27. The protein data bank. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE, Nucleic Acids Res 2000 28 235 242 (Pubitemid 30047768)
28. Structure validation by Cαgeometry: φ/ψ and Cβ deviation. Lovell SC, Davis IW, Arendall WB III, de Bakker PIW, Word JM, Prisant MG, Richardson JS, Richardson DC, Proteins: Structure, Function Genetics 2002 50 437 450
29. Verification of protein structures: patterns of nonbonded atomic interactions. Colovos C, Yeates TO, Protein Sci 1993 2 1511 1519 (Pubitemid 23262844)
30. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Wiederstein & Sippl, Nucleic Acids Res 2007 35 407 410
31. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. Trott O, Olson AJ, J Comput Chem 2010 31 455 461
32. 2,4,6-Trisubstituted pyrimidines as a new class of selective adenosine A, receptor antagonists. Chang LCW, Spanjersberg RF, von Frijtag DK, Unzel JK, Mulder-Krieger T, van den Hout G, J Med Chem 2004 47 6529 6540 (Pubitemid 39657315)
33. VEGA-An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script "programming" Pedretti A, Villa L, Vistoli G, J Comput Aided Mol Des 2004 18 167 173 (Pubitemid 39069412)
34. ChemDraw 8 ultra: windows and Macintosh versions. Mendelsohn LD, J Chem Inf Comput Sci 2004 44 2225 2226